Skip to main content
. 2021 Nov 12;14:756613. doi: 10.3389/fnmol.2021.756613

TABLE 2.

Selected reports utilizing iPSC models and organoid technologies for the characterization of schizophrenia.

 Sample origin In vitro model Observation(s) Implication(s) Sampling time frame Subtype selectivity References
fSZ/sSZ Fibroblasts iPSC, differentiated to neural progenitor cells Abnormal gene and protein levels related to cytoskeletal remodeling and increased oxidative stress SZ hiPSC NPCs may serve as a proxy for the developmental pathways potentially contributing to SZ pathogenesis Late-stage None Brennand et al., 2015
Fibroblasts iPSC, differentiated to CA3 neurons and DG neurons Reduction of activity in DG-CA3 co-culture and deficits in spontaneous and evoked activity in CA3 neurons iPSC-derived CA3 neurons and DG neurons may recapitulate SZ hippocampal activity Late-stage None Sarkar et al., 2018
Fibroblasts iPSC, differentiated to neural progenitor cells, glutamatergic neurons Reduced number of neurite and protein level of PSD95 Report decreased neuronal connectivity, synaptic protein level and glutamate receptor expression in SZ iPSC neurons Late-stage None Brennand et al., 2011
Fibroblasts iPSC, differentiated to dentate gyrus granule neurons Reduced hippocampal neurogenesis and attenuated spontaneous neurotransmitter release iPSC-derived DG granule neurons recapitulate SZ hippocampal neurogenesis features including lowered level of NEUROD1, PROX1 and TBR1 Late-stage None Yu et al., 2014
Fibroblasts iPSC, differentiated to forebrain mixed neurons Increase of gene expression of WNT signaling genes and β-catenin protein levels Abnormal expression of WNT signaling proteins may underlie SZ Late-stage None Topol et al., 2015
Fibroblasts iPSC-derived cerebral organoids Altered distribution of cortical neurons in correlation with abnormal expression of nuclear FGFR1 in neuronal committed cells Altered FGFR1 signaling is linked to cortical malformation in SZ patient-derived cerebral organoid models Late-stage None Stachowiak et al., 2017
Fibroblasts iPSC-derived cerebral organoids Increased production of malformative TNF and increased developmental vulnerability to TNF Development of brain pathology in SZ is exacerbated by abnormal TNF expression Late-stage None Benson et al., 2020
fSZ Fibroblasts iPSC, differentiated to neural progenitor cells Reduced protein level of CYFIP1 and WAVE 15q11.2 microdeletion affects neural developmental processes by altering CYFIP1 signaling and WAVE complex signaling Childhood-onset SZ 15q11.2 deletion Yoon et al., 2014
Fibroblasts iPSC, differentiated to neurons, neural progenitor cells and oligodendrocyte precursor cells Decreased expression of exon14-15 of CNTNAP2 and reduced neural migration Present that both exon-and allele-specific expression of CNTNAP2 may be critical for the predisposition of SZ Late-stage Large heterozygous CNTNAP2 deletion Lee et al., 2015
Hair follicle keratinocytes iPSC, differentiated to dopaminergic neurons and glutamatergic neurons Morphological abnormalities of dopaminergic neurons and mitochondrial dysfunction in keratinocytes Unravel impaired ability to differentiate into dopaminergic neurons and mitochondrial dysfunction including abnormal mitochondrial membrane potential, trafficking and turnover in SZ Late-stage Paranoid SZ Robicsek et al., 2013
Fibroblasts iPSC, differentiated to neural progenitor cells Downregulation of miR-9 in correlation with reduced migration in neural progenitor cells miR-9 as a risk factor for SZ Late-stage and childhood-onset SZ None Topol et al., 2016
sSZ Fibroblasts iPSC, differentiated to glutamatergic and GABAergic neurons Reduced expression of almost all genes in the 22q11.2 region Identified potential druggable targets in neuropsychiatric diseases associated with 22q11.2 del Late-stage 22q11.2 deletion Lin et al., 2016
Fibroblasts iPSC, differentiated to neural progenitor cells and neurospheres Reduced expression level of miRNAs belonging to miR-17/92 cluster and miR-106a/b and upregulated p38α Potential novel p38α-targeting therapeutics for SZ Late-stage 22q11.2 deletion Toyoshima et al., 2016
Fibroblasts iPSC, differentiated to mixed neurons Dysregulated expression of miRNAs Suggest that iPSCs derived from patient with 22q11.2 del SZ may be utilized to study the disease Late-stage and childhood-onset SZ 22q11.2 deletion Zhao et al., 2015
Fibroblasts iPSC, differentiation to forebrain mixed neurons and MAP2AB + neurons Reduced wild-type DISC1 protein level and synaptic vesicle release Mutant DISC1 depletes wild-type DISC1 protein and causes synaptic abnormalities including defects in glutamatergic synaptic transmission and synapse formation Late-stage DISC1 4-bp deletion Wen et al., 2014
Fibroblasts iPSC, differentiated to neural precursor cells Increase of extramitochondrial oxygen consumption and ROS level Abnormal metabolic changes during neurogenesis is associated with SZ Late-stage Clozapine resistant patient Paulsen Bda et al., 2012

fSZ, familial schizophrenia; sSZ, sporadic schizophrenia; DG, dentate gyrus; TNF, tumor necrosis factor; ROS, reactive oxygen species.